Comagine Health, a leading national, nonprofit health care consulting firm, announced that Emily R. Transue, MD, MHA, FACP, joined the company as chief clinical officer. Dr. Transue brings more than 20 years of clinical experience and has expertise in primary care, physician-owned multispecialty group leadership, Medicaid managed care and state public benefit programs, including Medicaid and public and school employee benefits.
Before joining Comagine Health, Dr. Transue served as a medical director at the Washington State Health Care Authority (HCA). During her tenure, she provided clinical leadership and oversight of all Public Employees Benefits Board (PEBB) and School Employees Benefits Board (SEBB) programs, including HCA’s Accountable Care Program and Centers of Excellence Program. In addition, she supported the initial years of the Medicaid Transformation Project and provided ongoing leadership of quality measurement and improvement efforts across both Medicaid and the PEBB and SEBB programs.
In her new role as chief clinical officer, Dr. Transue will partner with health care organizations across the country to identify strategies and implement innovations to help them improve the quality and reduce the cost of care for complex patient populations.
“We are thrilled to welcome Dr. Transue to Comagine Health,” said president and CEO Marc Bennett. “She is a well-known and widely respected physician who has spent her career improving the health of the people in her community. I have no doubt she’ll make an incredible impact at Comagine Health.”
Learn more about Dr. Transue and Comagine Health’s leadership team.